We were delighted to have the opportunity to speak with Indu Subramanian (Geffen School of Medicine, UCLA, and West Los Angeles Veterans Administration, Los Angeles, CA, USA) around the focus of her recently published article entitled: Synergy of pandemics-social isolation is associated with worsened Parkinson severity and quality of life, which was highlighted as a top abstract at the MDS Virtual Congress 2020.
1. What are the main reasons for social isolation in people with Parkinson’s disease (PD)? (0:06)
2. How can we promote activities that encourage social engagement among people with PD, both during the current restrictions and in the post-COVID era? (1:52)
See also the 2nd part of this interview here.
Disclosures: Dr Indu Subramanian has no financial or non-financial relationships or activities to declare in relation to this video interview.
Support: Interview and filming supported by Touch Medical Media.
Filmed as a highlight of the International Parkinson and Movement Disorder Society MDS Virtual Congress 2020.
Share this Video
Related Videos In Parkinson's Disease
Prof. K Ray Chaudhuri: Sleep Issues in Parkinson’s Disease – Diagnosis, Intervention & Practical Advice
In conjunction with the European Parkinson’s Disease Association (EPDA), we had the pleasure of meeting with Prof. K Ray Chaudhuri to discuss sleep issues among people with Parkinson’s Disease. The discussion highlights the appropriate diagnosis of sleep disorders, intervention strategies, practical advice for healthcare professionals, patients and caregivers, and the impact of sleep issues on […]
Raul Martinez-Fernandez, AAN 2021: Focused Ultrasound Subthalamotomy for Parkinson’s Disease
TouchNEUROLOGY met with Raul Martinez-Fernandez (University Hospital HM Puerta del Sur, Móstoles, Spain) to discuss the recent trial investigating focused ultrasound subthalamotomy and it’s role in the management of Parkinson’s Disease. The abstract entitled: ‘Randomized Trial of Focused Ultrasound Subthalamotomy for Parkinson’s Disease’ was presented at the American Academy of Neurology Virtual Annual Meeting 2021. […]
Stephen Pasternak, AD/PD 2021: Phase 2 trial Investigating Ambroxol as a Treatment for Parkinson’s Disease Dementia
It was a great pleasure to speak with Stephen Pasternak (University of Western Ontario, Ontario, Canada) to discuss the phase 2 trial investigating ambroxol as a disease-modifying treatment for Parkinson’s Disease dementia. The abstract entitled ‘Ambroxol as a Disease-modifying Treatment for Parkinson’s Disease Dementia: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial’ was presented at The […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!